Letybo vs. Botox: Why This FDA-Approved Wrinkle Relaxer Is Gaining Attention

For years, Botox has been one of the most recognizable names in wrinkle-relaxing treatments. But as the medical aesthetics industry continues to evolve, patients have more options than ever when it comes to smoothing fine lines and maintaining a refreshed, natural-looking appearance.

Enter Letybo, an FDA-approved botulinum toxin type A injectable that has gained international recognition and is making its mark in the U.S. market. To better understand the growing interest, we recently sat down with longtime client Sharonda Walton, ANP-BC, founder of Royalty Wellness Spa in Memphis, Tennessee, to discuss what patients should know about Letybo, how it compares with Botox, and why treatment selection matters.

First, What Is Letybo?

Letybo is a prescription injectable containing botulinum toxin type A. Like Botox Cosmetic, it works by temporarily reducing the muscle activity responsible for certain dynamic wrinkles—lines that form through repeated facial expressions.

In the United States, several FDA-approved botulinum toxin products are available for aesthetic use, including Botox Cosmetic, Dysport, Xeomin, Jeuveau, Daxxify, and Letybo. Although these products share a similar mechanism of action, they differ in formulation, dosing, approved indications, and other product-specific characteristics.

The takeaway? Botox is a brand name, not the name for every wrinkle relaxer. Understanding the available options can help patients have more informed conversations with their providers.

Why Are Patients Asking About Letybo?

According to Walton, several factors can influence a patient's interest in Letybo, from treatment costs to expectations around results and the importance of maintaining natural facial expression.

1. A Potentially Quick Onset of Results

Patients often want to know how soon they will see a difference after treatment. With Letybo, improvement may begin within the first several days, with results continuing to develop over approximately one to two weeks. Individual experiences vary based on factors such as the treatment area, dose, muscle activity, and individual response. As with other neuromodulators, patients should follow their provider's aftercare guidance and allow sufficient time to assess the full result.

2. An Additional Option for Treatment Budgets

Cost is an important consideration for patients who incorporate aesthetic treatments into their regular self-care routines. Letybo may be offered at a different price point than other neuromodulators, depending on the practice. However, per-unit prices are not directly interchangeable across products because dosing differs between formulations.

At Royalty Wellness Spa, the goal is to help patients understand their options and make informed decisions based on their aesthetic goals, treatment plan, and budget—without losing sight of safety or clinical expertise.

3. Natural-Looking Results That Preserve Expression

The goal of a wrinkle relaxer is not necessarily to eliminate every line or prevent facial movement altogether. For many patients, the preference is a refreshed appearance that still looks like them. Walton emphasizes the importance of individualized treatment planning. Facial anatomy, muscle strength, expression patterns, and patient preferences all influence how a provider approaches treatment. When administered appropriately, neuromodulators can soften targeted dynamic wrinkles. Results depend on the product, dose, injection technique, and individual response; no product can guarantee a particular aesthetic outcome.

4. Duration That Supports a Maintenance Routine

How long will results last? It is one of the most common questions patients ask before choosing a neuromodulator. Letybo's effects generally last around three to four months, although duration varies by individual and treatment area. Some patients may notice their muscle activity returning sooner, while others may experience longer-lasting effects.

A qualified provider can help determine an appropriate treatment interval based on the product's prescribing information, the patient's response, and their aesthetic goals.

5. Formulation and the Question of Treatment Resistance

Patients and providers may also be interested in the formulation of different botulinum toxin products. Some neuromodulators differ in their accessory proteins and manufacturing characteristics. However, it is important not to interpret these differences as proof that one product is less likely to cause treatment resistance in every patient. Neutralizing antibodies are one possible contributor to reduced response to botulinum toxin treatment, but clinical resistance is uncommon in aesthetic practice and can have multiple explanations. Current evidence does not establish that Letybo is categorically less likely than Botox to cause resistance. If a patient notices that a treatment is becoming less effective, a qualified provider can evaluate possible causes before recommending a change in product or treatment plan.

6. International Experience and FDA Approval

Letybo has been used in international markets under the Botulax brand name and has a history of use in South Korea. Its availability in the United States gives providers and patients another FDA-approved option within the neuromodulator category. International experience can provide useful context, but it should not be confused with a guarantee of safety or effectiveness for every individual. FDA approval, product-specific clinical evidence, appropriate patient selection, and qualified administration remain essential considerations. As with all botulinum toxin products, potential risks include injection-site reactions, headache, eyelid or brow drooping, and other adverse effects. Rarely, effects consistent with toxin spread can occur and may require urgent medical attention.

Does Letybo Replace Botox?

Not necessarily.

Letybo expands the options available to patients; it does not make every other neuromodulator obsolete.

The right product depends on the patient's goals, treatment history, anatomy, preferences, and the provider's clinical assessment. Rather than choosing a product based solely on brand recognition, social media buzz, or price, patients should discuss the benefits, limitations, and risks of the available options with a qualified medical professional.

The most valuable part of any aesthetic treatment is not simply the product selected. It is the combination of appropriate patient assessment, clinical expertise, realistic expectations, and individualized care.

Curious About Letybo?

For patients exploring wrinkle-relaxing treatments, a consultation is the best place to start. The team at Royalty Wellness Spa can help patients understand their options and determine whether a neuromodulator treatment is appropriate for their needs.

Phone: 901.410.8905

Website: RoyaltyWellnessSpa.com

Meet Sharonda Walton, ANP-BC

Sharonda Walton is a board-certified adult nurse practitioner, medical aesthetics educator, and founder of Royalty Wellness Spa in Memphis, Tennessee. A 2025 American Med Spa Association Distinguished Woman in Medical Aesthetics honoree, Walton is recognized for her leadership, clinical expertise, and commitment to ethical, inclusive aesthetic care.

At Royalty Wellness Spa, her work reflects a commitment to helping patients make informed decisions about their aesthetic goals while prioritizing individualized care and professional standards.